Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy

被引：1

作者：

Besse, B

Soria, JC

Le Chevalier, T ^{[1
]}

机构：

[1] Inst Gustave Roussy, Villejuif, France

[2] Natl Canc Inst, Paris, France

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷 / 07期

关键词：

D O I：

10.1093/annonc/mdi231

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：997 / 998

页数：2

相关论文

共 13 条

[1] Randomized phase III trial comparing cisplatin-etoposide to carhoplatin-paclitaxel in advanced or metastatic non-small cell lung cancer [J].

Belani, CP ;

Lee, JS ;

Socinski, MA ;

Robert, F ;

Waterhouse, D ;

Rowland, K ;

Ansari, R ;

Lilenbaum, R ;

Natale, RB .

ANNALS OF ONCOLOGY, 2005, 16 (07) :1069-1075

[2] Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an eastern cooperative oncology group trial [J].

Bonomi, P ;

Kim, KM ;

Fairclough, D ;

Cella, D ;

Kugler, J ;

Rowinsky, E ;

Jiroutek, M ;

Johnson, D .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :623-631

[3]

DELBALDO C, 2004, JAMA-J AM MED ASSOC, V92, P70

[4] Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].

Hanna, N ;

Shepherd, FA ;

Fossella, FV ;

Pereira, JR ;

De Marinis, F ;

von Pawel, J ;

Gatzemeier, U ;

Tsao, TCY ;

Pless, M ;

Muller, T ;

Lim, HL ;

Desch, C ;

Szondy, K ;

Gervais, R ;

Shaharyar ;

Manegold, C ;

Paul, S ;

Paoletti, P ;

Einhorn, L ;

Bunn, PA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597

[5] Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer [J].

Hotta, K ;

Matsuo, K ;

Ueoka, H ;

Kiura, K ;

Tabata, M ;

Tanimoto, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3852-3859

[6] Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese taxotere lung cancer study group [J].

Kubota, K ;

Watanabe, K ;

Kunitoh, H ;

Noda, K ;

Ichinose, Y ;

Katakami, N ;

Sugiura, T ;

Kawahara, M ;

Yokoyama, A ;

Yokota, S ;

Yoneda, S ;

Matsui, K ;

Kudo, S ;

Shibuya, M ;

Isobe, T ;

Segawa, Y ;

Nishiwaki, Y ;

Ohashi, Y ;

Niitani, H .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :254-261

[7] RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS [J].

LECHEVALIER, T ;

BRISGAND, D ;

DOUILLARD, JY ;

PUJOL, JL ;

ALBEROLA, V ;

MONNIER, A ;

RIVIERE, A ;

LIANES, P ;

CHOMY, P ;

CIGOLARI, S ;

GOTTFRIED, M ;

RUFFIE, P ;

PANIZO, A ;

GASPARD, MH ;

RAVAIOLI, A ;

BESENVAL, M ;

BESSEN, F ;

MARTINEZ, A ;

BERTHAUD, P ;

TURSZ, T .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) :360-367

[8]

Lynch TJ, 2005, J CLIN ONCOL, V23, p622S

[9] Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial [J].

Rosell, R ;

Gatzemeier, U ;

Betticher, DC ;

Keppler, U ;

Macha, HN ;

Pirker, R ;

Berthet, P ;

Breau, JL ;

Lianes, P ;

Nicholson, M ;

Ardizzoni, A ;

Chemaissani, A ;

Bogaerts, J ;

Gallant, G .

ANNALS OF ONCOLOGY, 2002, 13 (10) :1539-1549

[10]

Sandler AB, 2005, J CLIN ONCOL, V23, p2S